Clinical Trial Update: GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for GCSF therapy in decompensated cirrhosis across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis

Drugs mentioned

• GCSF therapy (granulocyte colony-stimulating factor)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Decompensated Cirrhosis of Liver | Phase 2, Phase 3 | Status: UNKNOWN